NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $63,000 | -26.7% | 3,500 | -30.0% | 0.03% | -20.9% |
| Q2 2021 | $86,000 | -14.0% | 5,000 | 0.0% | 0.04% | -20.4% |
| Q1 2021 | $100,000 | +17.6% | 5,000 | 0.0% | 0.05% | +14.9% |
| Q4 2020 | $85,000 | +2.4% | 5,000 | 0.0% | 0.05% | -7.8% |
| Q3 2020 | $83,000 | -28.4% | 5,000 | 0.0% | 0.05% | -31.1% |
| Q2 2020 | $116,000 | +30.3% | 5,000 | 0.0% | 0.07% | +12.1% |
| Q1 2020 | $89,000 | – | 5,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |